Werewolf Therapeutics, Inc.(HOWL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HOWL Werewolf Therapeutics, Inc.

盘后交易 09-16 18:41:47 EDT

0.9190

-0.0610

-6.22%

盘后0.9220

+0.0030+0.33%

18:14 EDT

最高0.9850	最低0.9190	成交量151.05万
今开0.9600	昨收0.9800	日振幅6.73%
总市值4,461万	流通市值4,403万	总股本4,854万
成交额144.27万	换手率3.15%	流通股本4,791万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"HOWL","market":"US","secType":"STK","nameCN":"Werewolf Therapeutics, Inc.","latestPrice":0.919,"timestamp":1789588800000,"preClose":0.98,"halted":0,"volume":1510531,"hourTrading":{"tag":"盘后","latestPrice":0.922,"preClose":0.919,"latestTime":"18:14 EDT","volume":69439,"amount":64574.2633697,"timestamp":1789596894153,"change":0.003,"changeRate":0.003264,"amplitude":0.047334},"delay":0,"changeRate":-0.062244897959183615,"floatShares":47914500,"shares":48540200,"eps":-0.750266,"marketStatus":"盘后交易","change":-0.061,"latestTime":"09-16 18:41:47 EDT","open":0.96,"high":0.985,"low":0.919,"amount":1442655.5916211999,"amplitude":0.067347,"askPrice":0.975,"askSize":300,"bidPrice":0.9001,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.750266,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"listingDate":1619755200000,"exchange":"NASDAQ","adjPreClose":0.98,"preHourTrading":{"tag":"盘前","latestPrice":0.96,"preClose":0.98,"latestTime":"09:07 EDT","volume":1944,"amount":1854.1117728,"timestamp":1789564030612,"change":-0.02,"changeRate":-0.020408,"amplitude":0.053367},"postHourTrading":{"tag":"盘后","latestPrice":0.922,"preClose":0.919,"latestTime":"18:14 EDT","volume":69439,"amount":64574.2633697,"timestamp":1789596894153,"change":0.003,"changeRate":0.003264,"amplitude":0.047334},"volumeRatio":1.6797,"impliedVol":2.1013,"impliedVolPercentile":0.4462},"requestUrl":"/m/hq/s/HOWL","defaultTab":"news","newsList":[{"id":"1131063695","title":"Werewolf Therapeutics：Ambros股东将依据交易协议所载公式获得新发行股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1131063695","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131063695?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:12","pubTimestamp":1787314350,"startTime":"0","endTime":"0","summary":"Werewolf Therapeutics宣布，根据双方达成的交易协议，Ambros公司股东将按照协议中明确规定的计算公式，获得Werewolf Therapeutics新发行的公司股份。此项安排意味着，Ambros的股东们将以既定比例换取这家生物技术公司的普通股，从而完成并购整合。具体而言，换股比例的确定将严格遵循交易文件中预先设定的公式框架，确保交易的公平性与透明度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HOWL","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169532350","title":"Werewolf Therapeutics合并后公司将由Ambros Therapeutics管理层领导，Joseph (Jay) Hagan出任CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=1169532350","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169532350?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:12","pubTimestamp":1787314349,"startTime":"0","endTime":"0","summary":"Werewolf Therapeutics宣布，合并后的公司将由Ambros Therapeutics的领导团队执掌帅印，Joseph (Jay) Hagan将担任首席执行官一职。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOWL","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196319280","title":"Werewolf Therapeutics并购交易股权分配揭晓：原股东持6.8%，Ambros股东持71.7%，私募配售投资者持21.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1196319280","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196319280?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:12","pubTimestamp":1787314348,"startTime":"0","endTime":"0","summary":"Werewolf Therapeutics公司日前披露了其与Ambros合并后的股权结构详情。根据最新公布的方案，合并后公司的股权将呈现三足鼎立之势——Werewolf Therapeutics原有股东将持有6.8%的股份，而Ambros股东则以71.7%的持股比例占据绝对主导地位，私募配售投资者则获得21.5%的股权份额。相比之下，Werewolf Therapeutics现有股东仅保留了个位数百分比的持股，这或许暗示着公司管理层及投资方对此次合并寄予厚望，愿意以稀释自身股权为代价，换取与新伙伴的战略协同效应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","HOWL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111661630","title":"Werewolf Therapeutics：换股交易基于Ambros隐含价值5亿美元（定向增发前）及公司隐含价值4750万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111661630","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111661630?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:03","pubTimestamp":1787313793,"startTime":"0","endTime":"0","summary":"Werewolf Therapeutics宣布，此次换股交易的定价依据已明确——Ambros在定向增发前的隐含估值高达5亿美元，而公司自身的隐含价值则为4750万美元。这一估值框架为整个交易奠定了坚实基础。Ambros凭借其前沿的研发管线与潜在市场影响力，被赋予了显著高于公司当前体量的价值评估。与此同时，Werewolf Therapeutics自身的4750万美元隐含估值，则反映了市场对其现有技术平台、临床进展及未来商业化潜力的综合判断。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","HOWL","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1141417062","title":"Werewolf Therapeutics：Ambros预期合并后公司资金充足，可支撑关键性Crps-Rise三期临床试验的顶线数据读出","url":"https://stock-news.laohu8.com/highlight/detail?id=1141417062","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141417062?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:03","pubTimestamp":1787313790,"startTime":"0","endTime":"0","summary":"Werewolf Therapeutics传来重要消息——该公司宣布，Ambros方面预计，在完成合并之后，新组建的实体将拥有充足的资金储备，足以支持其推进至关键性的Crps-Rise三期临床试验的顶线结果公布阶段。这一资金状况的明确，为合并后公司的研发进程提供了坚实的财务基础，确保了这一重要试验能够按计划顺利开展，直至最终读出关键数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HOWL","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101342895","title":"Werewolf Therapeutics合并后更名为Ambros Therapeutics，将以AMBX代码在纳斯达克交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1101342895","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101342895?lang=zh_cn&edition=full","pubTime":"2026-08-21 20:01","pubTimestamp":1787313671,"startTime":"0","endTime":"0","summary":"Werewolf Therapeutics——合并后的公司将以Ambros Therapeutics之名运营，并将在纳斯达克以AMBX为股票代码进行交易。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","HOWL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109071326","title":"Werewolf Therapeutics与默克达成资产转让协议：预付款2800万美元，交割后再付500万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1109071326","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109071326?lang=zh_cn&edition=full","pubTime":"2026-08-21 04:09","pubTimestamp":1787256554,"startTime":"0","endTime":"0","summary":"Werewolf Therapeutics公司披露，默克将支付2800万美元作为预付款，并在资产转让完成之际追加支付500万美元。对于专注于开发创新疗法的Werewolf Therapeutics而言，此次与默克的合作无疑为其研发管线注入了新的资金活力。2800万美元的前期投入加上500万美元的交割付款，虽非天文数字，却也足以体现默克对该资产的审慎评估与战略考量。随着交易推进，市场将密切关注后续交割条件是否如期达成，以及这笔资金将如何影响Werewolf Therapeutics的现金流状况和研发进度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","HOWL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122449553","title":"Werewolf Therapeutics于8月14日向默克雪兰诺出售Inducer与Indukine平台——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1122449553","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122449553?lang=zh_cn&edition=full","pubTime":"2026-08-21 04:09","pubTimestamp":1787256553,"startTime":"0","endTime":"0","summary":"Werewolf Therapeutics，一家专注于开发新型免疫疗法的生物制药公司，于8月14日宣布将旗下Inducer和Indukine两大技术平台出售给德国医药巨头默克雪兰诺。根据提交的SEC文件显示，此次出售涉及公司核心的诱导剂和免疫激酶平台，标志着Werewolf Therapeutics在战略重组方面迈出了重要一步。受此消息影响，Werewolf Therapeutics的股价在盘后交易中出现了小幅波动，投资者正密切关注公司后续的战略动向和财务状况变化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","HOWL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616031572","title":"Werewolf Therapeutics, Inc.盘中异动 早盘股价大跌6.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616031572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2616031572?lang=zh_cn&edition=full","pubTime":"2026-03-02 23:42","pubTimestamp":1772466139,"startTime":"0","endTime":"0","summary":"北京时间2026年03月02日23时42分，Werewolf Therapeutics, Inc.股票出现异动，股价大幅下挫6.55%。Werewolf Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.12%。Werewolf Therapeutics, Inc.公司简介：Werewolf Therapeutics Inc 是一家生物制药公司，致力于开创性地开发用于治疗癌症的、旨在刺激人体免疫系统的治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603022342199542a547&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603022342199542a547&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HOWL","BK4007","BK4139","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155710471","title":"狼人治疗公司2024年第四季度每股收益(GAAP EPS)$(0.46)，不及$(0.42)的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1155710471","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155710471?lang=zh_cn&edition=full","pubTime":"2025-03-11 20:12","pubTimestamp":1741695166,"startTime":"0","endTime":"0","summary":"狼人治疗公司报告本季度每股亏损$，低于分析师一致预期的$，低9.52%。相比去年同期每股亏损$，减少39.39%。此外，截至2024年12月31日，公司持有的现金及现金等价物为1.11亿美元，预计可以维持到2026年第二季度。以上内容来自Benzinga Earnings专栏，原文如下：Werewolf $Therapeutics$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 9.52 percent. This is a 39.39 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","HOWL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517394886","title":"Werewolf Therapeutics, Inc.盘中异动 早盘股价大涨5.13%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517394886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517394886?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:37","pubTimestamp":1741185437,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时37分，Werewolf Therapeutics, Inc.股票出现波动，股价急速拉升5.13%。Werewolf Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为392.62%、261.44%、193.43%，振幅较大的相关个股有Aditxt, Inc.、Silexion Therapeutics Corp、Bioxcel Therapeutics, Inc.，振幅分别为23.90%、20.71%、15.91%。Werewolf Therapeutics, Inc.公司简介：Werewolf Therapeutics Inc 是一家生物制药公司，致力于开创性地开发用于治疗癌症的、旨在刺激人体免疫系统的治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223718963addd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223718963addd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","HOWL","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516392677","title":"Werewolf Therapeutics, Inc.盘中异动 大幅下跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516392677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516392677?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:31","pubTimestamp":1741098696,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时31分，Werewolf Therapeutics, Inc.股票出现波动，股价快速跳水5.26%。Werewolf Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Exicure, Inc.、Protagenic Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1047.99%、1025.13%、405.62%，振幅较大的相关个股有Bolt Biotherapeutics、Adma Biologics Inc、Orchestra Biomed Holdings, Inc.，振幅分别为8.83%、7.01%、6.10%。Werewolf Therapeutics, Inc.公司简介：Werewolf Therapeutics Inc 是一家生物制药公司，致力于开创性地开发用于治疗癌症的、旨在刺激人体免疫系统的治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422313696394423&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422313696394423&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","HOWL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514233202","title":"Werewolf Therapeutics, Inc.盘中异动 临近收盘急速跳水6.25%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514233202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514233202?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:33","pubTimestamp":1740688415,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时33分，Werewolf Therapeutics, Inc.股票出现波动，股价大幅下跌6.25%。Werewolf Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Xortx Therapeutics Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1932.04%、385.40%、196.36%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Werewolf Therapeutics, Inc.公司简介：Werewolf Therapeutics Inc 是一家生物制药公司，致力于开创性地开发用于治疗癌症的、旨在刺激人体免疫系统的治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280433359632f2b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280433359632f2b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HOWL","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511252522","title":"Werewolf Therapeutics, Inc.盘中异动 早盘急速拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511252522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511252522?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:35","pubTimestamp":1739457303,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时35分，Werewolf Therapeutics, Inc.股票出现波动，股价快速拉升5.24%。Werewolf Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Edesa Biotech, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Dominari Holdings Inc.涨幅较大，Tc Biopharm  Plc、Edesa Biotech, Inc.、Genprex, Inc.较为活跃，换手率分别为996.67%、833.90%、95.55%，振幅较大的相关个股有Edesa Biotech, Inc.、Fibrobiologics, Inc.、Pliant Therapeutics, Inc.，振幅分别为25.80%、16.76%、13.60%。Werewolf Therapeutics, Inc.公司简介：Werewolf Therapeutics Inc 是一家生物制药公司，致力于开创性地开发用于治疗癌症的、旨在刺激人体免疫系统的治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322350398842c45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322350398842c45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HOWL","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510605088","title":"Werewolf Therapeutics, Inc.盘中异动 股价大跌5.10%报1.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510605088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510605088?lang=zh_cn&edition=full","pubTime":"2025-02-11 01:04","pubTimestamp":1739207040,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日01时04分，Werewolf Therapeutics, Inc.股票出现波动，股价快速跳水5.10%。Werewolf Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Werewolf Therapeutics, Inc.公司简介：Werewolf Therapeutics Inc 是一家生物制药公司，致力于开创性地开发用于治疗癌症的、旨在刺激人体免疫系统的治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211010400a240c1eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211010400a240c1eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","LENZ","HOWL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509466743","title":"Werewolf Therapeutics, Inc.盘中异动 早盘股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509466743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509466743?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:12","pubTimestamp":1738685573,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时12分，Werewolf Therapeutics, Inc.股票出现波动，股价大幅上涨5.12%。Werewolf Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.35%。其相关个股中，Azitra Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Quoin Pharmaceuticals Ltd涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1625.35%、924.25%、429.25%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Quoin Pharmaceuticals Ltd，振幅分别为72.82%、49.88%、47.29%。Werewolf Therapeutics, Inc.公司简介：Werewolf Therapeutics Inc 是一家生物制药公司，致力于开创性地开发用于治疗癌症的、旨在刺激人体免疫系统的治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001253987a5aec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001253987a5aec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HOWL","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508141068","title":"Werewolf Therapeutics, Inc.盘中异动 股价大跌5.95%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508141068","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508141068?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:47","pubTimestamp":1738594077,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时47分，Werewolf Therapeutics, Inc.股票出现异动，股价大幅跳水5.95%。Werewolf Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为417.42%、353.58%、221.79%，振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Invivyd, Inc.，振幅分别为82.67%、50.76%、35.62%。Werewolf Therapeutics, Inc.公司简介：Werewolf Therapeutics Inc 是一家生物制药公司，致力于开创性地开发用于治疗癌症的、旨在刺激人体免疫系统的治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224757a2380d96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224757a2380d96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HOWL","LENZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503425506","title":"Werewolf Therapeutics, Inc.盘中异动 早盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503425506","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503425506?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:31","pubTimestamp":1736951486,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时31分，Werewolf Therapeutics, Inc.股票出现异动，股价大幅拉升5.19%。Werewolf Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Generation Bio Co.、Exicure, Inc.、Monte Rosa Therapeutics, Inc.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为184.63%、51.92%、35.31%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Vincerx Pharma, Inc.、Onconetix, Inc.，振幅分别为12.00%、10.72%、9.31%。Werewolf Therapeutics, Inc.公司简介：Werewolf Therapeutics Inc 是一家生物制药公司，致力于开创性地开发用于治疗癌症的、旨在刺激人体免疫系统的治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223126a222fda4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223126a222fda4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4139","HOWL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503571086","title":"Werewolf Therapeutics, Inc.盘中异动 急速上涨5.18%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503571086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503571086?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:51","pubTimestamp":1736866294,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时51分，Werewolf Therapeutics, Inc.股票出现波动，股价急速上涨5.18%。Werewolf Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Werewolf Therapeutics, Inc.公司简介：Werewolf Therapeutics Inc 是一家生物制药公司，致力于开创性地开发用于治疗癌症的、旨在刺激人体免疫系统的治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114225134abaab185&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114225134abaab185&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HOWL","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2491726363","title":"Werewolf Therapeutics, Inc.盘中异动 股价大跌5.26%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491726363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2491726363?lang=zh_cn&edition=full","pubTime":"2024-12-14 00:07","pubTimestamp":1734106033,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日00时07分，Werewolf Therapeutics, Inc.股票出现异动，股价急速跳水5.26%。Werewolf Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Werewolf Therapeutics, Inc.公司简介：Werewolf Therapeutics Inc 是一家生物制药公司，致力于开创性地开发用于治疗癌症的、旨在刺激人体免疫系统的治疗药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214000713a1ec5fa5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214000713a1ec5fa5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HOWL","BK4139","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.werewolftx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":1.4215},{"period":"3month","weight":1.8488},{"period":"6month","weight":0.2097},{"period":"1year","weight":-0.3147},{"period":"ytd","weight":0.547}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":-0.0244},{"period":"3month","weight":0.0222},{"period":"6month","weight":0.1479},{"period":"1year","weight":0.146},{"period":"ytd","weight":0.1107}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Werewolf Therapeutics, Inc.于2017年10月19日根据特拉华州法律注册成立。该公司是一家创新的生物制药公司，致力于开发旨在刺激机体免疫系统来治疗癌症的疗法。该公司正在利用公司专有的PREDATOR平台设计条件性激活的分子，刺激适应性免疫和先天性免疫，以解决传统促炎性免疫疗法的局限性。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.173073},{"month":2,"riseRate":0.2,"avgChangeRate":-0.033126},{"month":3,"riseRate":0.2,"avgChangeRate":-0.075322},{"month":4,"riseRate":0.2,"avgChangeRate":-0.064351},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.013868},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.103355},{"month":7,"riseRate":0.333333,"avgChangeRate":0.001511},{"month":8,"riseRate":0.833333,"avgChangeRate":0.30961},{"month":9,"riseRate":0.333333,"avgChangeRate":0.027186},{"month":10,"riseRate":0.4,"avgChangeRate":-0.078425},{"month":11,"riseRate":0,"avgChangeRate":-0.186184},{"month":12,"riseRate":0.4,"avgChangeRate":-0.021765}],"exchange":"NASDAQ","name":"Werewolf Therapeutics, Inc.","nameEN":"Werewolf Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Werewolf Therapeutics, Inc.(HOWL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Werewolf Therapeutics, Inc.(HOWL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Werewolf Therapeutics, Inc.,HOWL,Werewolf Therapeutics, Inc.股票,Werewolf Therapeutics, Inc.股票老虎,Werewolf Therapeutics, Inc.股票老虎国际,Werewolf Therapeutics, Inc.行情,Werewolf Therapeutics, Inc.股票行情,Werewolf Therapeutics, Inc.股价,Werewolf Therapeutics, Inc.股市,Werewolf Therapeutics, Inc.股票价格,Werewolf Therapeutics, Inc.股票交易,Werewolf Therapeutics, Inc.股票购买,Werewolf Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Werewolf Therapeutics, Inc.(HOWL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Werewolf Therapeutics, Inc.(HOWL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}